VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Activity of alemtuzumab in patients with CD52-positive acute leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Activity of alemtuzumab in patients with CD52-positive acute leukemia.
Activity of alemtuzumab in patients with CD52-positive acute leukemia. Cancer. 2006 Jun 15; 106(12):2645-51.
View in:
PubMed
subject areas
Acute Disease
Adolescent
Adult
Aged
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Antigens, CD
Antigens, Neoplasm
Bacteremia
Bone Marrow
CD52 Antigen
Disease Progression
Dose-Response Relationship, Drug
Drug Resistance, Neoplasm
Female
Fungemia
Glycoproteins
Humans
Leukemia, Myeloid
Male
Middle Aged
Pneumonia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Treatment Outcome
authors with profiles
JORGE E CORTES
FARHAD RAVANDI-KASHANI
ALESSANDRA FERRAJOLI
SRDAN VERSTOVSEK
GUILLERMO GARCIA-MANERO
WILLIAM G WIERDA